Jul 02

M.M DILLON & CO SERVES AS NEGOTIATOR BETWEEN RIGHTON DIAGNOSTICS AND AKONNI FOR A $7.5M EQUITY INVESTMENT

Akonni is a molecular diagnostic company. We closed on a $7.5M equity investment in the company by the Chinese diagnostic company Righton Diagnostics. Akonni’s Core product lines include TruTip sample prep kits and the TruDiagnosis system for multiplexed diagnostics. TruTip is a robust nucleic acid extraction technology. Trudiagnosis is a unique in vitro diagnosis system. MM Dillon acted as the go between the two companies and negotiated all terms of the investment by Righton.

About M.M. Dillon & Co.

M.M. Dillon & Co. (formerly CRT Investment Banking LLC) is an employee owned partnership where industry and product specialists collaborate closely to provide creative, idea-driven advice and solutions to its institutional and corporate clients. M.M. Dillon offers public and private financing, M&A advisory and restructuring advisory services. M.M. Dillon’s team of experienced professionals provides execution capabilities for companies across a range of industry sectors. The firm’s senior banking professionals have a minimum of 20 years of experience with major Wall Street firms.